News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,310 Results
Type
Article (64166)
Company Profile (291)
Press Release (685853)
Multimedia
Podcasts (58)
Webinars (12)
Section
Business (212420)
Career Advice (2376)
Deals (36318)
Drug Delivery (102)
Drug Development (84619)
Employer Resources (178)
FDA (16608)
Job Trends (15543)
News (359138)
Policy (34040)
Tag
Academia (2921)
Academic (1)
Accelerated approval (5)
Adcomms (22)
Allergies (88)
Alliances (52746)
ALS (94)
Alzheimer's disease (1455)
Antibody-drug conjugate (ADC) (135)
Approvals (16604)
Artificial intelligence (270)
Autoimmune disease (23)
Automation (16)
Bankruptcy (367)
Best Places to Work (11968)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (198)
Bladder cancer (80)
Brain cancer (29)
Breast cancer (286)
Cancer (2329)
Cardiovascular disease (181)
Career advice (1983)
Career pathing (32)
CAR-T (160)
Cell therapy (448)
Cervical cancer (20)
Clinical research (68256)
Collaboration (878)
Compensation (535)
Complete response letters (21)
COVID-19 (2771)
CRISPR (44)
C-suite (255)
Cystic fibrosis (104)
Data (2236)
Decentralized trials (2)
Denatured (21)
Depression (48)
Diabetes (276)
Diagnostics (6585)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (126)
Drug pricing (106)
Drug shortages (26)
Duchenne muscular dystrophy (96)
Earnings (87749)
Editorial (43)
Employer branding (22)
Employer resources (153)
Events (116867)
Executive appointments (750)
FDA (17886)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (784)
Gene editing (110)
Generative AI (23)
Gene therapy (321)
GLP-1 (749)
Government (4661)
Grass and pollen (5)
Guidances (65)
Healthcare (19605)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (122)
Indications (30)
Infectious disease (2920)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (97)
Interviews (404)
IPO (16771)
IRA (44)
Job creations (4000)
Job search strategy (1685)
Kidney cancer (10)
Labor market (38)
Layoffs (496)
Leadership (19)
Legal (8210)
Liver cancer (77)
Lung cancer (328)
Lymphoma (158)
Machine learning (7)
Management (61)
Manufacturing (320)
MASH (70)
Medical device (13666)
Medtech (13671)
Mergers & acquisitions (20090)
Metabolic disorders (706)
Multiple sclerosis (85)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (2015)
NextGen: Class of 2025 (6824)
Non-profit (4849)
Now hiring (39)
Obesity (373)
Opinion (224)
Ovarian cancer (76)
Pain (91)
Pancreatic cancer (84)
Parkinson's disease (152)
Partnered (22)
Patents (237)
Patient recruitment (111)
Peanut (48)
People (60070)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (21300)
Phase II (29951)
Phase III (22238)
Pipeline (1215)
Policy (148)
Postmarket research (2939)
Preclinical (9576)
Press Release (70)
Prostate cancer (109)
Psychedelics (33)
Radiopharmaceuticals (262)
Rare diseases (395)
Real estate (6472)
Recruiting (67)
Regulatory (23305)
Reports (46)
Research institute (2626)
Resumes & cover letters (392)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (73)
Series A (135)
Series B (85)
Service/supplier (17)
Sickle cell disease (56)
Special edition (15)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3835)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (42)
The Weekly (35)
Vaccines (743)
Venture capitalists (41)
Weight loss (248)
Women's health (36)
Worklife (17)
Date
Today (188)
Last 7 days (896)
Last 30 days (2708)
Last 365 days (33726)
2025 (10955)
2024 (36155)
2023 (41082)
2022 (52363)
2021 (57004)
2020 (55657)
2019 (48499)
2018 (36593)
2017 (33837)
2016 (33872)
2015 (40479)
2014 (34373)
2013 (30535)
2012 (32095)
2011 (32478)
2010 (31054)
Location
Africa (883)
Alabama (55)
Alaska (7)
Arizona (245)
Arkansas (13)
Asia (41668)
Australia (7285)
California (6197)
Canada (2030)
China (539)
Colorado (268)
Connecticut (279)
Delaware (150)
Europe (93426)
Florida (918)
Georgia (211)
Idaho (59)
Illinois (559)
India (27)
Indiana (311)
Iowa (11)
Japan (165)
Kansas (107)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (910)
Massachusetts (4675)
Michigan (220)
Minnesota (403)
Mississippi (2)
Missouri (82)
Montana (31)
Nebraska (25)
Nevada (64)
New Hampshire (65)
New Jersey (1749)
New Mexico (31)
New York (1778)
North Carolina (1030)
North Dakota (9)
Northern California (2701)
Ohio (209)
Oklahoma (14)
Oregon (35)
Pennsylvania (1389)
Puerto Rico (12)
Rhode Island (33)
South America (1243)
South Carolina (24)
South Dakota (1)
Southern California (2323)
Tennessee (103)
Texas (922)
United States (23570)
Utah (186)
Virginia (150)
Washington D.C. (66)
Washington State (563)
West Virginia (3)
Wisconsin (57)
750,310 Results for "bc research inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Battling Bird Flu: Genome BC Funds Critical Research to Protect BC from Avian Influenza
February 20, 2025
·
6 min read
Press Releases
Patent Granted to BC3 Technologies for SEAL Hemostatic Wound Spray
April 16, 2025
·
4 min read
Press Releases
Microbix Presenting at Investor Conference in B.C.
February 19, 2025
·
4 min read
Press Releases
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
March 13, 2025
·
3 min read
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Press Releases
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
March 12, 2025
·
4 min read
Press Releases
nference and BeiGene Collaborate to Drive New B-Cell Cancer Research
April 17, 2025
·
2 min read
Press Releases
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc.
February 26, 2025
·
4 min read
Drug Development
Screening Completed: Berlin Cures Achieves Key Milestone in BC 007 Phase II Trial for Treatment of Long COVID
Berlin Cures announced the successful completion of patient screening for its pan-European Phase II trial of BC 007, a novel therapeutic candidate for the treatment of Long COVID.
April 23, 2024
·
2 min read
1 of 75,031
Next
